Enoxaparin Sodium recalls

Enoxaparin Sodium products have been recalled 3 times, most recently on 3 Sep 2025. The recalling company is usually Sanofi-Aventis U.S. The most common reason is packaging defects.

Total recalls3since 2018

Last 12 months0reported

Class I00% of total

Ongoing1latest 3 Sep 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 1 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why enoxaparin sodium is recalled

Packaging Defects267%
Manufacturing (CGMP) Deviations133%

Companies

Product types

Blood Thinners3100%

By year

2025133%
2024133%
2018133%

Ongoing enoxaparin sodium recalls

1 active

Reported	Class	Recall	Company	Reason	Where
3 Sep 2025Drug	CLASS II	Enoxaparin Sodium Injection, USP, 30 mg recalled by Cardinal HealthEnoxaparin Sodium	Cardinal Health	Packaging Defects	KS

All enoxaparin sodium recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
3 Sep 2025Drug	CLASS II	Enoxaparin Sodium Injection, USP, 30 mg recalled by Cardinal HealthEnoxaparin Sodium	Cardinal Health	Packaging Defects	KS
3 Jan 2024Drug	CLASS II	Enoxaparin Sodium Injection recalled by Cardinal HealthcareEnoxaparin Sodium	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide
17 Jan 2018Drug	CLASS III	Enoxaparin Sodium, Injection 120 mg/, pre-filled recalledEnoxaparin Sodium	Sanofi-Aventis U.S	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.